Skip to main content

Advertisement

SpringerLink
Log in

Dasatinib as a Probable Cause of Bilateral Chylothorax in a Patient with Chronic Myeloid Leukemia: Case Report

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Dasatinib-induced chylothorax has been sporadically reported, and its pathophysiology has yet to be fully elucidated. We report a 53-year-old man with underlying chronic myeloid leukemia in remission on regular dasatinib who was referred to pulmonology team with an incidental finding of a right upper lobe lung nodule with bilateral pleural effusion on chest radiograph. Computed tomography confirmed a solid spiculated solitary pulmonary nodule (SPN) with bilateral pleural effusions with no mediastinal or intra-abdominal lymphadenopathy. Initial diagnostic thoracentesis of the left pleural effusion revealed serous fluid, which was exudative with negative cytology and medical thoracoscopic pleural biopsy yielded only chronic inflammatory changes. Post-procedurally, as appetite further improved, intercostal tube drainage turn chylous, centrifugation and triglyceride levels confirmed chylothorax. Diagnostic thoracentesis was then done over the right pleural effusion, which revealed serous appearance, biochemically exudative with triglyceride of 1.7 mmol/l. Bilateral chylothorax probably due to dasatinib was suspected, and the drug was withheld. Chest tube was removed after 10 days. PET/CT scan showed only hypermetabolism in the SPN and hilar lymph node with no mediastinal involvement. Tuberculosis workup was negative. The SPN was biopsied under fluoroscopy-guided bronchoscopy, which confirmed limited stage neuroendocrine carcinoma of the lung. Patient remained well at 1 month follow-up with no recurrence of bilateral chylothorax. We discuss the implications of concurrent bilateral exudative chylothorax in SPN and the diagnostic challenges of chylothorax.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CML:

Chronic myeloid leukemia

CT:

Computed tomography

LDH:

Lactate dehydrogenase

PET/CT:

Positron emission tomography/computed tomography

Pf:

Pleural fluid

R-EBUS:

Radial endobronchial ultrasound

SPN:

Solitary pulmonary nodule

TKI:

Tyrosine kinase inhibitor

References

  1. Ferreiro L, San-Jose E, Suarez-Antelo J, et al. Dasatinib-induced pleural effusion: chylothorax, an option to consider. Ann Thorac Med. 2016;11(4):289–93.

    Article  CAS  Google Scholar 

  2. Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med. 2010;16:387–93.

    Article  Google Scholar 

  3. Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009;84(2):129–33.

    Article  Google Scholar 

  4. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med. 1997;157(8):849–55.

    Article  CAS  Google Scholar 

  5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

    Article  CAS  Google Scholar 

  6. Caldemeyer L, Dugan M, Edwards J, Akard L. Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia. Curr Hematol Malig Rep. 2016;11(2):71–9.

    Article  Google Scholar 

  7. Huang YM, Wang CH, Huang JS, Yeh KY, Lai CH, Wu TH, et al. Dasatinib-related chylothorax. Turk J Hematol. 2015;32:68–72.

    Article  CAS  Google Scholar 

  8. Chua AT, Cleven KL, Wharton R, et al. Chylothorax and pulmonary arterial hypertension after treatment with dasatinib: a case report. Ann Clin Case Rep. 2017;2:1408.

    Google Scholar 

  9. Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest. 2008;133:1436–41.

    Article  Google Scholar 

  10. Navokovic S, Peic AK, Holik K, et al. Neuroendocrine tumour of cecum in patient treated with imatinib mesylate for blastic phase of chronic myeloid leukemia. Acta Clin Belg. 2017:1–4. https://doi.org/10.1080/17843286.2017.1316005.

  11. Carter BW, Glisson BS, Truong MT, Erasmus JJ. Small cell lung carcinoma: staging, imaging, and treatment considerations. RadioGraphics. 2014;34:1707–21.

    Article  Google Scholar 

  12. Vakil E, Ost D, Vial MR, et al. Non-specific pleuritis in patients with active malignancy. Respirology. 2017;23:213–9.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank our colleagues from Hematology Unit, Sarawak General Hospital for co-managing this patient. We would also like to express our deepest gratitude to the Sarawak Lung Cancer Special Interest Group (SLCSIG) in providing valuable insights in the management of this case.

Author information

Authors and Affiliations

  1. Division of Respiratory Medicine, Department of Medicine, Sarawak General Hospital, Ministry of Health, Jalan Hospital, 93586, Kuching, Sarawak, Malaysia

    Sze Shyang Kho, Larry Ellee Nyanti, Chan Sin Chai & Siew Teck Tie

Authors
  1. Sze Shyang Kho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Larry Ellee Nyanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chan Sin Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siew Teck Tie
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SSK initiated the idea for case reporting. SSK and LEN prepared the final copy of the manuscript. SSK and CSC were involved in the overall management of the patient under the supervision of STT. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Sze Shyang Kho.

Ethics declarations

Conflict of Interests

The authors declare that they have no conflict of interest.

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is attached and available for review by the Editor-in-Chief of this journal.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kho, S.S., Nyanti, L.E., Chai, C.S. et al. Dasatinib as a Probable Cause of Bilateral Chylothorax in a Patient with Chronic Myeloid Leukemia: Case Report. SN Compr. Clin. Med. 2, 817–821 (2020). https://doi.org/10.1007/s42399-020-00280-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-020-00280-6

Keywords

Search

Navigation